Piedmont Capital Management (North Carolina)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$820K Buy
892
+32
+4% +$32.4K 0.55% 28
2025
Q4
$924K Buy
+860
New +$822K 0.61% 27

Other funds holding LLY

Piedmont Capital Management (North Carolina)'s LLY Position: Q1 2026 in Review

Piedmont Capital Management (North Carolina) increased its Eli Lilly (LLY) stake by 3.7% in Q1 2026, buying an estimated $32.4K and bringing the position to 892 shares worth $820K. The position accounts for 0.55% of the portfolio, ranked #28.

Piedmont Capital Management (North Carolina) first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $924K in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Piedmont Capital Management (North Carolina) held 892 shares of Eli Lilly worth $820K as of Q1 2026.
  • Piedmont Capital Management (North Carolina) bought 32 Eli Lilly shares in Q1 2026, an estimated $32.4K.
  • Eli Lilly made up 0.55% of Piedmont Capital Management (North Carolina)'s portfolio in Q1 2026, its #28 holding.
  • Piedmont Capital Management (North Carolina) first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Piedmont Capital Management (North Carolina)'s Eli Lilly position peaked at $924K in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Piedmont Capital Management (North Carolina)'s 13F filing for Q1 2026, filed 21 Apr 2026.